Autologous T-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies.

Overview

authors

Elías, Esteban Enrique

Almejún, María Belén

Cordini, Gregorio

Vergara-Rubio, Maricef

Podaza, Enrique
Risnik, Denise
Cabrejo, María
Fernández-Grecco, Horacio
Bezares, Raimundo Fernando
Custidiano, María Del Rosario
Sánchez-Ávalos, Julio César
Vicente, Ángeles
Garate, Gonzalo Martín
Borge, Mercedes
Giordano, Mirta
Gamberale, Romina

publication date

May 10, 2018

published in

Haematologica Journal

Research

keywords

Bridged Bicyclo Compounds, Heterocyclic
Drug Resistance, Neoplasm
Leukemia, Lymphocytic, Chronic, B-Cell
Lymphocyte Activation
Neoplasm Proteins
Sulfonamides
Syk Kinase
T-Lymphocytes

Identity

PubMed Central ID

PMC6165796

Scopus Document Identifier

85054347708

Digital Object Identifier (DOI)

10.3324/haematol.2018.188680

PubMed ID

29748439

Additional Document Info

has global citation frequency

13

volume

103

issue

10